BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 9, 2007
View Archived Issues
Sunesis Pharmaceuticals reports recent data on two lead compounds
Read More
Therapeutic silencing of mutant huntingtin in transgenic HD mice yields promising results
Read More
Gene-Activated human glucocerebrosidase active and safe in Gaucher's disease
Read More
Transition reports update on diabetes program
Read More
Phase I studies delineate pharmacokinetics of elvitegravir in healthy volunteers
Read More
Etanercept ineffective in severe asthma
Read More
Exelixis has numerous poster presentations at AACR-NCI-EORTC conference
Read More
New therapeutic agents for gastrointestinal disorders reported in recent patents
Read More
Preclinical data provide detail on the mechanism of action of trodusquemine
Read More
Arformoterol pharmacokinetics, QTc effects and dosing variability examined
Read More
Osteologix reports positive top-line results from STRONG clinical trial of NB-S101
Read More
MDV-3100 demonstrates reductions in prostate-specific antigen in phase I/II trial
Read More
AstraZeneca secures option for exclusive license to Targacept's TC-5619
Read More
Derma acquires licensing contract for DSC-127 from the University of Southern California
Read More
Epix identifies three lead candidates in G-protein-coupled receptor discovery program
Read More
FDA to review Abbott's premarket approval submission for Xience V
Read More
Clinical study supports expanded indication of BioThrax for post-exposure prophylaxis
Read More
Novacea ends ASCENT-2 trial of Asentar for androgen-independent prostate cancer
Read More
New antipsychotic agents emerge from GlaxoSmithKline R&D
Read More
GSK initiates ENABLE 1 and ENABLE 2 phase III trials of eltrombopag
Read More
IntelGenx and Cary Pharmaceuticals enter definitive agreement for CPI-300 antidepressant
Read More
CombinatoRx initiates phase IIa clinical trial of CRx-191 for psoriasis
Read More
Poniard reports positive preliminary data from ongoing phase I trial of oral picoplatin
Read More
Locus signs second research agreement with Ono for preclinical kinase drug candidates
Read More
MacroChem reports positive interim data from phase II study of EcoNail
Read More
Systemically administered calpain inhibitor effective in animal models of SAH
Read More
Dual H3 antagonist/SERT inhibitor in development at J&J for depression
Read More
Abbott characterizes novel analgesic CB2 receptor agonist
Read More
In vitro and in vivo activity of new 5-HT2C inverse agonist characterized in San Diego
Read More
FDA approves Abilify for adolescent patients aged 13-17 years with schizophrenia
Read More
STEP study confirms Merck & Co.'s investigational HIV vaccine V-520 was not effective
Read More